The EPS beat is a positive signal, but the lack of a guidance raise or disclosed partnership revenue limits the upside.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 10 $231.14entry
- T+1 · 2mo ago +1.68%α +0.83% · $235.02
- T+5 · 2mo ago +7.06%α +7.56% · $247.45
- T+20 · 6w ago −0.14%α −2.27% · $230.81
- T+47 · todayOpen
- T+60 · in 18d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Quest Diagnostics reported Q2 2026 EPS of $3.12, a 9.0% beat vs the $2.86 consensus, and announced a partnership with Apple to offer lab testing through the Apple Health app. The EPS beat is notable, but the Apple Health integration is a long-term consumer growth catalyst with no immediate financial impact disclosed.
Key Financial Metrics
Key Facts
- Q2 2026 EPS of $3.12 beat consensus of $2.86 by 9.0%
- Revenue not explicitly stated in the provided filing document; set to null
- Announced partnership with Apple to offer a 50+ biomarker lab test panel via the Apple Health app later this year
- The lab panel will be available for $119 at approximately 2,000 Quest patient service centers
- No guidance change or revenue figures for the partnership were disclosed
Financial Impact
EPS beat of $0.26 per share vs consensus; partnership revenue potential undisclosed
Risk Factors
- No guidance raise was provided, which may cap the stock's upside
- The Apple Health partnership has no disclosed revenue or margin impact, creating uncertainty about its materiality
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302874147 |
Track record
24 reports on DGX
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +5.88% at T+20 after the Jul 23, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 12, 20263d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 5, 202610d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers